As a metabolic disease, T2DM is characterized by insulin secreted from pancreatic β cells that cannot meet the demands of insulin sensitivity or insulin resistance, which might result from over-nutrition with chronic hyperglycaemia and hyperlipidaemia. The gene discussed is INS; the disease is hyperlipidemia.